Literature DB >> 27940684

Cytokine Elevation in Sudden Death With Respiratory Syncytial Virus: A Case Report of 2 Children.

Yu Kakimoto1, Yoshihisa Seto1, Eriko Ochiai1, Fumiko Satoh1, Motoki Osawa2.   

Abstract

Respiratory syncytial virus (RSV) is the most common viral cause of bronchiolitis and pneumonia in young children worldwide. Premature birth, bronchopulmonary dysplasia, congenital heart disease, and Down syndrome are risk factors for high mortality and prolonged morbidity after RSV infection. Conversely, many previously healthy, full-term children are also admitted to the hospital because of RSV, and some of them experience severe sequelae or die due to the virus. Various complications of RSV infection have been reported, such as encephalopathy, encephalitis, and cardiomyopathy. However, the pathogenesis of serious cases in children without an underlying disease has not been elucidated. In this report, we present 2 RSV-related deaths of children who were born at full-term and developed normally up to the age of 19 months. Their cardiopulmonary arrests occurred within half a day after the onset of symptoms, such as cough and high fever. Many postmortem examinations were performed to investigate their unexpected deaths. Histopathological examinations revealed extensive bronchiolitis and mild pneumonia accompanying airway obstruction. Immunostaining revealed the presence of the virus mainly in bronchial epithelia, but not in alveoli. Complete brain edema was prominent, and encephalopathy was developing. Blood tests revealed that the IL-6 level was elevated more than >200-fold above normal, despite a normal C-reactive protein level. Because IL-6 may reflect the severity of bronchial epithelial damage and contribute to brain edema, an extreme elevation of IL-6 may predict the risk for sudden death in children with RSV infection.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27940684     DOI: 10.1542/peds.2016-1293

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.

Authors:  Eun-Jin Choi; Yuping Ren; Yu Chen; Shengxuan Liu; Wenzhe Wu; Junping Ren; Pingyuan Wang; Roberto P Garofalo; Jia Zhou; Xiaoyong Bao
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

2.  Respiratory syncytial virus-associated mortality in a healthy 3-year-old child: a case report.

Authors:  A Gavotto; A Ousselin; O Pidoux; P Cathala; V Costes-Martineau; B Rivière; J L Pasquié; P Amedro; C Rambaud; G Cambonie
Journal:  BMC Pediatr       Date:  2019-11-27       Impact factor: 2.125

Review 3.  Genetic influences on viral-induced cytokine responses in the lung.

Authors:  Jessica L Forbester; Ian R Humphreys
Journal:  Mucosal Immunol       Date:  2020-11-12       Impact factor: 7.313

4.  Nasal-spraying Bacillus spores as an effective symptomatic treatment for children with acute respiratory syncytial virus infection.

Authors:  Dien Minh Tran; Tu Thanh Tran; Thuy Thi Bich Phung; Huyen Thi Bui; Phuc Thanh Thi Nguyen; Tam Thi Vu; Nga Thi Phuong Ngo; Mai Thi Nguyen; Anh Hoa Nguyen; Anh Thi Van Nguyen
Journal:  Sci Rep       Date:  2022-07-20       Impact factor: 4.996

5.  Fatal Pediatric COVID-19 Case With Seizures and Fulminant Cerebral Edema.

Authors:  Siddharth Ninan; Peyton Thompson; Timothy Gershon; Natalie Ford; William Mills; Valerie Jewells; Leigh Thorne; Katherine Saunders; Thomas Bouldin; Jason R Smedberg; Melissa B Miller; Eveline Wu; Alyssa Tilly; Jeremy Sites; Daniel Lercher; Katherine Clement; Tracie Walker; Paul Shea; Benny Joyner; Rebecca Smith
Journal:  Child Neurol Open       Date:  2021-06-14

6.  Severe Respiratory Syncytial Virus Infection.

Authors:  Yasuyo Kashiwagi; Toshihiro Nakayama; Masahiro Kimura; Tomoko Maeda; Soken Go; Hisashi Kawashima; Akihito Sawada; Tetsuo Nakayama
Journal:  Indian J Pediatr       Date:  2019-12-21       Impact factor: 1.967

Review 7.  COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.

Authors:  Patrick C Bradshaw; William A Seeds; Alexandra C Miller; Vikrant R Mahajan; William M Curtis
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.